Follow us...

 

Search News Archives

Monthly Newsletter

 

Lab Bulletin August Newsletter

view the latest issue

Subscribe

News Channels

 

New Laboratory Products

 

Lab News

 

Microscopy & Image Analysis

 

Separation Science

 

Research & Case Studies

 

Literature

 

Videos

 

Events | Webinars

 

 

 

Conferences | Events

Thermo Fisher Scientific Enhances Workflow for Biomarker Research and Diagnostics

Thermo Fisher Scientific Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has enhanced its workflow for biomarker research and diagnostics by acquiring Intrinsic Bioprobes Inc., a manufacturer of unique immuno-enrichment, sample-preparation tools used in quantitative mass spectrometry. The Intrinsic Bioprobes portfolio enables Thermo Fisher to offer its worldwide life science research and clinical diagnostics customers an enhanced solution for quantitative protein biomarker detection.

The Intrinsic Bioprobes portfolio includes its novel Mass Spectrometric Immunoassay (MSIATM), featuring a patented sample preparation technique. This technology allows enrichment of low-abundance proteins in biological samples. The specificity of immuno-enrichment, coupled with the sensitivity and quantitative capability of mass spectrometry, is a powerful tool, giving researchers a complete, higher-resolution view of the proteome. Furthermore, the MSIA technology offers clear advantages over conventional ELISA and bead-based immunoassay formats, providing greater sensitivity and higher throughput. 

Adding Intrinsic Bioprobes' consumable sample-preparation technologies to Thermo Fisher's automated sample processing and quantitative mass spectrometry instruments and software creates a complete, integrated workflow for the quantitative detection of protein biomarkers. 

"The Intrinsic Bioprobes portfolio will enhance Thermo Fisher's position in the rapidly emerging field of clinical proteomics," said Chuck Kummeth, president of Thermo Fisher's, laboratory consumables business. "It is a simple, yet powerful approach to uncovering the proteomic basis of disease, and it better positions us to support our customers in their efforts to realize the promise of personalized medicine."

Intrinsic Bioprobes was founded by in 1996 by Randall W. Nelson, who has served as its president since then. He will continue to be involved with the business as a consultant.

For more information visit www.thermofisher.com.


If you have not logged into the website then please enter your details below.



 

 

Popular this Month...

Our Top 10 most popular articles this month

 

Today's Picks...

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd

 


Promotions

 

Media Partners